Creoptix Company

Creoptix develops optical instruments and consumables for the label-free analysis of molecular interactions for the drug discovery industry. It offers instrument sets for fragment-based screening or binding analysis at low concentrations and slow dissociation kinetics; sensors that provides versatile carboxyl-coupling for a range of molecules; andCreoptix software, which integrates assay setup and data evaluation in one tool.
Industry: Medical Technology
Headquarters: Zurich

Visit Website
Register and Claim Ownership